Harm Reduction

The COVID-19 pandemic has led to significant disruptions in California’s efforts to expand and improve services for HIV, hepatitis C, sexually transmitted diseases, and harm reduction. On November 18, 2020, the California HIV/AIDS Policy Research Centers and the End the Epidemics coalition convened a community meeting to discuss these challenges and to identify priorities for […]

Read More
Harm Reduction
Improving HIV, HCV, STD, and Harm Reduction Services in the Era of COVID-19 and Beyond

December 21, 2020

People living with HIV (PLWH) experience a disproportionate rate of trauma compared to the general population and trauma’s association with poorer treatment adherence, health outcomes and increased risk behavior has long been known. Current literature examines sources and experiences of trauma among PLWH, including intimate partner violence, gender violence, experiencing and witnessing violence, child abuse, […]

Read More
Harm Reduction
Evaluating Trauma-Informed Care Practices Among HIV Care Providers in California

December 31, 2019

In the first of a two-part series, we explore the impact of the opioid epidemic on HIV and other health conditions in California and Nevada. This brief outlines the intersections between the HIV and opioid epidemics in two heavily impacted western states: California and Nevada. The opioid crisis, which is driven largely by the misuse […]

Read More
Harm Reduction
HIV and Opioid Use in California and Nevada

December 23, 2019

Prior authorization requirements have been considered a successful cost containment strategy for health insurance companies. However, previous research indicates that such requirements have negative impacts on medication access and patient adherence. California Senate Bill 159 is a current proposal to prohibit health plans and insurers from requiring prior authorization and step therapy requirements for Pre-exposure […]

Read More
Harm Reduction
Evaluating the Impact of Prior Authorization Requirements for PrEP and PEP in California

September 14, 2019

In 2015, California saw over 4,700 new cases of HIV. Nationally, in the same year, California led the nation for HIV transmissions via injection drug use and among men who have sex with men who inject drugs. Other key groups impacted by both epidemics include women, people of color, those who are homeless and youth. […]

Read More
Harm Reduction
HIV and Safer Drug Consumption Programs in California

March 19, 2018

Covered California is the state’s health insurance marketplace where qualified residents of California can purchase affordable health insurance. Given recent events in Washington D.C., you may have questions about how actions taken by the federal government will impact your health coverage. This guide is designed specifically to help people living with HIV and hepatitis C […]

Read More
Harm Reduction
Covered California Frequently Asked Questions

November 1, 2017

On April 6, 2017, the California HIV/AIDS Policy Research Centers convened a statewide group of stakeholders to discuss best practices for HIV prevention and care within transgender communities in California. Presentations by leading experts from academic medical centers and community-based organizations focused on utilizing an intersectionality perspective to identify best practices for serving transgender populations […]

Read More
Harm Reduction
Best Practices for Trans HIV Prevention and Care: Addressing Social Determinants of Health

July 10, 2017

Despite a year-long outbreak of invasive meningococcal disease in Southern California primarily affecting gay and bisexual men, less than 27% of men who have sex with men (MSM) in Los Angeles County have been vaccinated for meningitis. The findings, released by the California HIV/AIDS Policy Research Centers collaboration between UCLA, the Los Angeles LGBT Center, […]

Read More
Harm Reduction
Vaccination Response to an Ongoing Meningitis Outbreak: Uptake and Attitudes among Men Who Have Sex with Men in Los Angeles, CA

March 13, 2017